Your browser doesn't support javascript.
loading
Wogonin attenuates inflammation by activating PPAR-γ in alcoholic liver disease.
Li, Hai-Di; Chen, Xin; Yang, Yang; Huang, Hui-Min; Zhang, Ling; Zhang, Xin; Zhang, Lei; Huang, Cheng; Meng, Xiao-Ming; Li, Jun.
Afiliação
  • Li HD; The Key Laboratory of Major Autoimmune Diseases, Anhui Province, Anhui Institute of Innovative Drugs, School of Pharmacy, Anhui Medical University, China; The Key Laboratory of Anti-inflammatory of Immune Medicines, Ministry of Education, China; Institute for Liver Diseases of Anhui Medical Universi
  • Chen X; The Key Laboratory of Major Autoimmune Diseases, Anhui Province, Anhui Institute of Innovative Drugs, School of Pharmacy, Anhui Medical University, China; The Key Laboratory of Anti-inflammatory of Immune Medicines, Ministry of Education, China; Institute for Liver Diseases of Anhui Medical Universi
  • Yang Y; The Key Laboratory of Major Autoimmune Diseases, Anhui Province, Anhui Institute of Innovative Drugs, School of Pharmacy, Anhui Medical University, China; The Key Laboratory of Anti-inflammatory of Immune Medicines, Ministry of Education, China; Institute for Liver Diseases of Anhui Medical Universi
  • Huang HM; The Key Laboratory of Major Autoimmune Diseases, Anhui Province, Anhui Institute of Innovative Drugs, School of Pharmacy, Anhui Medical University, China; The Key Laboratory of Anti-inflammatory of Immune Medicines, Ministry of Education, China; Institute for Liver Diseases of Anhui Medical Universi
  • Zhang L; The Key Laboratory of Major Autoimmune Diseases, Anhui Province, Anhui Institute of Innovative Drugs, School of Pharmacy, Anhui Medical University, China; The Key Laboratory of Anti-inflammatory of Immune Medicines, Ministry of Education, China; Institute for Liver Diseases of Anhui Medical Universi
  • Zhang X; The Key Laboratory of Major Autoimmune Diseases, Anhui Province, Anhui Institute of Innovative Drugs, School of Pharmacy, Anhui Medical University, China; The Key Laboratory of Anti-inflammatory of Immune Medicines, Ministry of Education, China; Institute for Liver Diseases of Anhui Medical Universi
  • Zhang L; The Key Laboratory of Major Autoimmune Diseases, Anhui Province, Anhui Institute of Innovative Drugs, School of Pharmacy, Anhui Medical University, China; The Key Laboratory of Anti-inflammatory of Immune Medicines, Ministry of Education, China; Institute for Liver Diseases of Anhui Medical Universi
  • Huang C; The Key Laboratory of Major Autoimmune Diseases, Anhui Province, Anhui Institute of Innovative Drugs, School of Pharmacy, Anhui Medical University, China; The Key Laboratory of Anti-inflammatory of Immune Medicines, Ministry of Education, China; Institute for Liver Diseases of Anhui Medical Universi
  • Meng XM; The Key Laboratory of Major Autoimmune Diseases, Anhui Province, Anhui Institute of Innovative Drugs, School of Pharmacy, Anhui Medical University, China; The Key Laboratory of Anti-inflammatory of Immune Medicines, Ministry of Education, China; Institute for Liver Diseases of Anhui Medical Universi
  • Li J; The Key Laboratory of Major Autoimmune Diseases, Anhui Province, Anhui Institute of Innovative Drugs, School of Pharmacy, Anhui Medical University, China; The Key Laboratory of Anti-inflammatory of Immune Medicines, Ministry of Education, China; Institute for Liver Diseases of Anhui Medical Universi
Int Immunopharmacol ; 50: 95-106, 2017 Sep.
Article em En | MEDLINE | ID: mdl-28646664
ABSTRACT
Alcoholic liver disease (ALD) is one of the predominant causes of liver-related morbidity and mortality worldwide. However, effective therapy for ALD is still lacking. Wogonin, a major flavonoid compound, is found in Scutellaria baicalensis Georgi. Accumulating studies have revealed that wogonin possesses anti-inflammatory and anti-tumour activities in various models. However, the hepatoprotective activity of wogonin in ALD is still obscure. In this study, we found that wogonin significantly attenuated inflammatory response in EtOH-fed mice, and reduced the expression of inflammatory cytokines such as TNF-α and IL-6 in EtOH-induced RAW264.7 cells. Furthermore, our findings showed that wogonin remarkably induced the expression of PPAR-γ in vivo and in vitro. Compared with the wogonin-treated group, blockade of PPAR-γ with inhibitor (T0070907) or PPAR-γ small interfering (si)-RNA were applied in RAW264.7 cells to evaluate the involvement of wogonin in alleviating EtOH-induced inflammation. Moreover, forced expression of PPAR-γ further suppressed the expression of TNF-α and IL-6 when treated with wogonin on EtOH-induced RAW264.7 cells. In addition, it was demonstrated that wogonin remarkably suppressed PPAR-γ-meditated phosphorylation and activation of NF-κB-P65. In conclusion, our results indicated that wogonin may serve as an effective modulator of PPAR-γ by down-regulating NF-κB pathway, thereby attenuated inflammatory response in ALD.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Métodos Terapêuticos e Terapias MTCI: Terapias_biologicas / Plantas_medicinales Assunto principal: Flavanonas / PPAR gama / Hepatopatias Alcoólicas / Anti-Inflamatórios Tipo de estudo: Prognostic_studies Idioma: En Revista: Int Immunopharmacol Ano de publicação: 2017 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Métodos Terapêuticos e Terapias MTCI: Terapias_biologicas / Plantas_medicinales Assunto principal: Flavanonas / PPAR gama / Hepatopatias Alcoólicas / Anti-Inflamatórios Tipo de estudo: Prognostic_studies Idioma: En Revista: Int Immunopharmacol Ano de publicação: 2017 Tipo de documento: Article